LISATA THERAPEUTICS, INC. — Director's Dealing 2012

Sep 18, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. ((NBS)
CIK: 0000320017
Period of Report: 2012-09-18

Reporting Person: Smith Robin L (Director, Chairman of the Board and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-09-18	Common stock, $0.001 par value per share	P	36000	$0.69	Acquired	1749533	Direct